Bioventus Inc. (BVS) NASDAQ

$8.65 -0.06 (-0.69%)

Market Cap: $534.45M

As of 05/19/22 03:59 PM EDT. Market closed.

(BVS)

Bioventus Inc. (BVS) NASDAQ

$8.65 -0.06 (-0.69%)

Market Cap: $534.45M

As of 05/19/22 03:59 PM EDT. Market closed.

Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations For Active Healing from Bioventus include offerings for osteoarthritis, surgical and non-surgical bone healing. Built on a commitment to high quality standards, evidence-based medicine and ... read more

Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations For Active Healing from Bioventus include offerings for osteoarthritis, surgical and non-surgical bone healing. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Surgical and Medical Instrument Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Surgical and Medical Instrument Manufacturing
Full Time Employees
700
Address
.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
KEY STATS
Open
$8.71
Previous Close
$8.71
Days Range
$8.50 - $9.11
52 week range
$7.31 - $19.94
Volume
181,224
Avg. Volume (30 days)
344,637
Market Cap
$534.45M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
61,360,214
Open
$8.71
Previous Close
$8.71
Days Range
$8.50 - $9.11
52 week range
$7.31 - $19.94
Volume
181,224
Avg. Volume (30 days)
344,637
Market Cap
$534.45M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
61,360,214

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR BIOVENTUS INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
D'Adamio Anthony SVP & General Counsel Apr 04, 2022 Sale $11.19 16,016 179,238 40,132 Apr 05, 2022, 09:16 PM
Nosenzo John Chief Commercial Officer Apr 04, 2022 Sale $11.12 65,963 733,502 83,932 Apr 05, 2022, 09:14 PM
Pavesio Alessandra SVP & Chief Science Officer Apr 04, 2022 Sale $11.17 32,997 368,425 148,309 Apr 05, 2022, 09:09 PM
Pavesio Alessandra SVP & Chief Science Officer Feb 14, 2022 Sale $11.99 433 5,192 119,830 Feb 16, 2022, 06:29 PM
D'Adamio Anthony SVP & General Counsel Feb 14, 2022 Sale $11.99 1,294 15,513 18,672 Feb 15, 2022, 09:31 PM
Anglum Gregory O. SVP & CFO Feb 14, 2022 Sale $11.99 1,294 15,518 55,013 Feb 15, 2022, 09:27 PM
Nosenzo John Chief Commercial Officer Feb 14, 2022 Sale $11.99 534 6,401 43,370 Feb 15, 2022, 09:17 PM
Pavesio Alessandra SVP & CHIEF SCIENCE OFFICER Feb 10, 2022 Option Exercise $12.88 73,915 952,025 118,793 Feb 14, 2022, 08:43 PM
Nosenzo John CHIEF COMMERCIAL OFFICER Feb 10, 2022 Option Exercise $12.88 24,205 311,760 42,434 Feb 14, 2022, 08:41 PM
D'Adamio Anthony SVP & General Counsel Feb 10, 2022 Option Exercise $12.88 6,599 84,995 15,566 Feb 14, 2022, 08:37 PM
Anglum Gregory O. SVP & CFO Feb 10, 2022 Option Exercise $12.88 19,674 253,401 51,907 Feb 14, 2022, 08:35 PM
Reali Kenneth Michael CHIEF EXECUTIVE OFFICER Sep 09, 2021 Buy $14.81 1,800 26,658 11,175 Sep 10, 2021, 09:22 AM
Anglum Gregory O. SVP & General Counsel Feb 11, 2021 Buy $13.00 6,000 78,000 6,000 Apr 05, 2021, 04:35 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
D'Adamio Anthony SVP & General Counsel 04/04/2022 179,238
Nosenzo John Chief Commercial Officer 04/04/2022 733,502
Pavesio Alessandra SVP & Chief Science Officer 04/04/2022 368,425
Pavesio Alessandra SVP & Chief Science Officer 02/14/2022 5,192
D'Adamio Anthony SVP & General Counsel 02/14/2022 15,513
Anglum Gregory O. SVP & CFO 02/14/2022 15,518
Nosenzo John Chief Commercial Officer 02/14/2022 6,401
Pavesio Alessandra SVP & CHIEF SCIENCE OFFICER 02/10/2022 952,025
Nosenzo John CHIEF COMMERCIAL OFFICER 02/10/2022 311,760
D'Adamio Anthony SVP & General Counsel 02/10/2022 84,995
Anglum Gregory O. SVP & CFO 02/10/2022 253,401
Reali Kenneth Michael CHIEF EXECUTIVE OFFICER 09/09/2021 26,658
Anglum Gregory O. SVP & General Counsel 02/11/2021 78,000
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
04/02/2022
04/03/2021
44.71%
4Q

Period of Report: 04/02/2022

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
04/03/2021
44.71%
4Q